Search Results - Alessandro Armuzzi
-
1
GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
Published 2025-07-01Get full textGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) represent a cornerstone in the treatment of diabetes and obesity and have emerged as a promising option for other metabolic disorders, including hepatic steatosis. Recent evidence highlights the direct and indirect anti-inflammatory properties of...
Article -
2
Digital biomarkers and artificial intelligence: a new frontier in personalized management of inflammatory bowel disease
Published 2025-08-01Get full textBackground and aimsArtificial intelligence (AI) is rapidly gaining traction in gastroenterology, particularly in the management of inflammatory bowel disease (IBD). Given the complexity of IBD care, AI offers the potential to enhance diagnosis, monitoring, and treatment. This review aims to summariz...
Article -
3
Collecting and Analyzing IBD Clinical Data for Machine-Learning: Insights from an Italian Cohort
Published 2025-06-01Get full textResearch of Inflammatory Bowel Disease (IBD) involves integrating diverse and heterogeneous data sources, from clinical records to imaging and laboratory results, which presents significant challenges in data harmonization and exploration. These challenges are also reflected in the development of ma...
Article